Rikke Riber-Hansen

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. doi Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C, 8000, Denmark
    Ann Surg Oncol 15:1492-501. 2008
  2. doi Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    APMIS 116:199-205. 2008
  3. ncbi Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
    Johanne Lade-Keller
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    J Clin Pathol 67:520-8. 2014
  4. doi Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Histopathology 59:433-40. 2011
  5. doi Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma
    Patricia S Nielsen
    Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Mod Pathol 26:404-13. 2013
  6. doi Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions
    Patricia Switten Nielsen
    Department of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C, Denmark
    Arch Pathol Lab Med 136:627-34. 2012
  7. doi Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus, Denmark
    Eur J Cancer 48:347-52. 2012
  8. doi Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Cancer 115:2177-87. 2009
  9. doi The nodal location of metastases in melanoma sentinel lymph nodes
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Am J Surg Pathol 33:1522-8. 2009
  10. ncbi Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark
    Histopathology 54:796-803. 2009

Collaborators

Detail Information

Publications14

  1. doi Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C, 8000, Denmark
    Ann Surg Oncol 15:1492-501. 2008
    ..We aimed to design a protocol that reduced this workload without compromising metastasis detection...
  2. doi Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    APMIS 116:199-205. 2008
    ..009). This suggests that the presence of submicroscopic metastases may influence prognosis, indicating that RT-PCR detection of melanocytic cells in SLNs may be an important diagnostic marker...
  3. ncbi Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
    Johanne Lade-Keller
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    J Clin Pathol 67:520-8. 2014
    ..To perform immunohistochemical (IHC) analysis of molecular drivers related to the development and maintenance of melanoma and to assess their value as diagnostic and prognostic melanoma biomarkers in routine clinical practice...
  4. doi Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Histopathology 59:433-40. 2011
    ..However, it is somewhat laborious for routine application. Our aim was to investigate whether digital image analysis can estimate TMV accurately in melanoma SLNs...
  5. doi Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma
    Patricia S Nielsen
    Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Mod Pathol 26:404-13. 2013
    ..This was particularly true for thick melanomas whereas no specific analyses for thin melanomas only could be performed...
  6. doi Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions
    Patricia Switten Nielsen
    Department of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C, Denmark
    Arch Pathol Lab Med 136:627-34. 2012
    ..Instead, digital image analysis of Ki67/MART1 double stains may provide fast and novel index computations for entire tumor sections...
  7. doi Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus, Denmark
    Eur J Cancer 48:347-52. 2012
    ..We performed a prospective multicentre study to compare the European Organisation for Research and Treatment of Cancer (EORTC) recommended protocol with a protocol of complete step-sectioning...
  8. doi Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Cancer 115:2177-87. 2009
    ..Melanoma metastasis size estimates are of prognostic significance for groups of patients, but to the authors' knowledge, measurement consensus does not exist...
  9. doi The nodal location of metastases in melanoma sentinel lymph nodes
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    Am J Surg Pathol 33:1522-8. 2009
    ..The design of melanoma sentinel lymph node (SLN) histologic protocols is based on the premise that most metastases are found in the central parts of the nodes, but the evidence for this belief has never been thoroughly tested...
  10. ncbi Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survival
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark
    Histopathology 54:796-803. 2009
    ..The aim was to use objective stereological techniques to correlate accurately total SLN tumour burden with recurrence and patient survival...
  11. doi Tumor and inflammation markers in melanoma using tissue microarrays: a validation study
    Trine Ollegaard Jensen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
    Melanoma Res 21:509-15. 2011
    ..We conclude that TMA technology combined with simplified grading systems are appropriate for analyzing both inflammation and tumor cell markers in melanoma...
  12. doi Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions
    Patricia Switten Nielsen
    Department of Pathology, Aarhus University Hospital, 8000 Aarhus, Denmark
    Am J Dermatopathol 33:361-70. 2011
    ..The IHC double stains may potentially reduce misinterpretations of melanomas in histopathology...
  13. doi Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas
    Johanne Lade-Keller
    Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
    J Mol Diagn 15:70-80. 2013
    ..CADMA and TaqMan may not require macrodissections for a reliable test. Therefore, the use of more sensitive methods may have a future in testing for BRAF mutations in clinical settings...
  14. doi Digital image analysis: a review of reproducibility, stability and basic requirements for optimal results
    Rikke Riber-Hansen
    Institute of Pathology, Aarhus University Hospital, Denmark
    APMIS 120:276-89. 2012
    ....